Literature DB >> 33686212

Automated identification of clinical features from sparsely annotated 3-dimensional medical imaging.

Srinivas R Sadda1,2, Eran Halperin3,4,5,6,7, Nadav Rakocz8, Jeffrey N Chiang9, Muneeswar G Nittala1, Giulia Corradetti1,2, Liran Tiosano1,10, Swetha Velaga1, Michael Thompson8, Brian L Hill8, Sriram Sankararaman8,9,11, Jonathan L Haines12, Margaret A Pericak-Vance13, Dwight Stambolian14.   

Abstract

One of the core challenges in applying machine learning and artificial intelligence to medicine is the limited availability of annotated medical data. Unlike in other applications of machine learning, where an abundance of labeled data is available, the labeling and annotation of medical data and images require a major effort of manual work by expert clinicians who do not have the time to annotate manually. In this work, we propose a new deep learning technique (SLIVER-net), to predict clinical features from 3-dimensional volumes using a limited number of manually annotated examples. SLIVER-net is based on transfer learning, where we borrow information about the structure and parameters of the network from publicly available large datasets. Since public volume data are scarce, we use 2D images and account for the 3-dimensional structure using a novel deep learning method which tiles the volume scans, and then adds layers that leverage the 3D structure. In order to illustrate its utility, we apply SLIVER-net to predict risk factors for progression of age-related macular degeneration (AMD), a leading cause of blindness, from optical coherence tomography (OCT) volumes acquired from multiple sites. SLIVER-net successfully predicts these factors despite being trained with a relatively small number of annotated volumes (hundreds) and only dozens of positive training examples. Our empirical evaluation demonstrates that SLIVER-net significantly outperforms standard state-of-the-art deep learning techniques used for medical volumes, and its performance is generalizable as it was validated on an external testing set. In a direct comparison with a clinician panel, we find that SLIVER-net also outperforms junior specialists, and identifies AMD progression risk factors similarly to expert retina specialists.

Entities:  

Year:  2021        PMID: 33686212      PMCID: PMC7940637          DOI: 10.1038/s41746-021-00411-w

Source DB:  PubMed          Journal:  NPJ Digit Med        ISSN: 2398-6352


  29 in total

1.  3D Deep Learning for Multi-modal Imaging-Guided Survival Time Prediction of Brain Tumor Patients.

Authors:  Dong Nie; Han Zhang; Ehsan Adeli; Luyan Liu; Dinggang Shen
Journal:  Med Image Comput Comput Assist Interv       Date:  2016-10-02

2.  Photoreceptor integrity line joins the nerve fiber layer as key to clinical diagnosis.

Authors:  Jerome Sherman
Journal:  Optometry       Date:  2009-06

3.  Altered Brain Developmental Trajectories in Adolescents After Initiating Drinking.

Authors:  Adolf Pfefferbaum; Dongjin Kwon; Ty Brumback; Wesley K Thompson; Kevin Cummins; Susan F Tapert; Sandra A Brown; Ian M Colrain; Fiona C Baker; Devin Prouty; Michael D De Bellis; Duncan B Clark; Bonnie J Nagel; Weiwei Chu; Sang Hyun Park; Kilian M Pohl; Edith V Sullivan
Journal:  Am J Psychiatry       Date:  2017-10-31       Impact factor: 18.112

4.  OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.

Authors:  Marco Nassisi; Jianqin Lei; Nizar Saleh Abdelfattah; Ayesha Karamat; Siva Balasubramanian; Wenying Fan; Akihito Uji; Kenneth M Marion; Kirstie Baker; Xiwen Huang; Elizabeth Morgenthien; Srinivas R Sadda
Journal:  Ophthalmology       Date:  2019-05-29       Impact factor: 12.079

5.  Quantity of Intraretinal Hyperreflective Foci in Patients With Intermediate Age-Related Macular Degeneration Correlates With 1-Year Progression.

Authors:  Marco Nassisi; Wenying Fan; Yue Shi; Jianqin Lei; Enrico Borrelli; Michael Ip; Srinivas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-07-02       Impact factor: 4.799

Review 6.  Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography.

Authors:  Dilraj S Grewal; Angelo P Tanna
Journal:  Curr Opin Ophthalmol       Date:  2013-03       Impact factor: 3.761

7.  Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation.

Authors:  Konstantinos Kamnitsas; Christian Ledig; Virginia F J Newcombe; Joanna P Simpson; Andrew D Kane; David K Menon; Daniel Rueckert; Ben Glocker
Journal:  Med Image Anal       Date:  2016-10-29       Impact factor: 8.545

8.  Automated Detection of Macular Diseases by Optical Coherence Tomography and Artificial Intelligence Machine Learning of Optical Coherence Tomography Images.

Authors:  Soichiro Kuwayama; Yuji Ayatsuka; Daisuke Yanagisono; Takaki Uta; Hideaki Usui; Aki Kato; Noriaki Takase; Yuichiro Ogura; Tsutomu Yasukawa
Journal:  J Ophthalmol       Date:  2019-04-09       Impact factor: 1.909

Review 9.  Evaluation of age-related macular degeneration with optical coherence tomography.

Authors:  Pearse A Keane; Praveen J Patel; Sandra Liakopoulos; Florian M Heussen; Srinivas R Sadda; Adnan Tufail
Journal:  Surv Ophthalmol       Date:  2012-09       Impact factor: 6.048

10.  AMISH EYE STUDY: Baseline Spectral Domain Optical Coherence Tomography Characteristics of Age-Related Macular Degeneration.

Authors:  Muneeswar G Nittala; Yeunjoo E Song; Rebecca Sardell; Larry D Adams; Samuel Pan; Swetha B Velaga; Violet Horst; Debra Dana; Laura Caywood; Renee Laux; Denise Fuzzell; Sarada Fuzzell; William K Scott; Jessica N Cooke Bailey; Robert P Igo; Jonathan Haines; Margaret A Pericak-Vance; SriniVas R Sadda; Dwight Stambolian
Journal:  Retina       Date:  2019-08       Impact factor: 3.975

View more
  1 in total

Review 1.  Advances in Optical Coherence Tomography Imaging Technology and Techniques for Choroidal and Retinal Disorders.

Authors:  Joshua Ong; Arman Zarnegar; Giulia Corradetti; Sumit Randhir Singh; Jay Chhablani
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.